289 related articles for article (PubMed ID: 8277579)
21. Central determinants of attention and mood disorder in tardive dyskinesia ("tardive dysmentia").
Myslobodsky MS
Brain Cogn; 1993 Sep; 23(1):88-101. PubMed ID: 8217124
[TBL] [Abstract][Full Text] [Related]
22. Management of tardive dyskinesia: current update.
Simpson GM; Pi EH; Sramek JJ
Drugs; 1982 May; 23(5):381-93. PubMed ID: 7047137
[TBL] [Abstract][Full Text] [Related]
23. [Neuroleptic-induced movement disorders: historical perspectives].
Wolf MA; Yassa R; Llorca PM
Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
[TBL] [Abstract][Full Text] [Related]
24. [Utility of quetiapine in tardive dyskinesia].
Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
[TBL] [Abstract][Full Text] [Related]
25. Comparison of severe and mild tardive dyskinesia: implications for etiology.
Gardos G; Cole JO; Schniebolk S; Salomon M
J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
[TBL] [Abstract][Full Text] [Related]
26. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
Berger PA; Rexroth K
Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
[TBL] [Abstract][Full Text] [Related]
27. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
Lee JG; Shin BS; Lee YC; Park SW; Kim YH
Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
[TBL] [Abstract][Full Text] [Related]
28. The use of clonidine in the treatment of neuroleptic-induced tardive dyskinesia.
Browne J; Silver H; Martin R; Hart R; Mergener M; Williams P
J Clin Psychopharmacol; 1986 Apr; 6(2):88-92. PubMed ID: 2871058
[TBL] [Abstract][Full Text] [Related]
29. Clinical and epidemiologic aspects of tardive dyskinesia.
Baldessarini RJ
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of tardive dyskinesia.
Tepper SJ; Haas JF
J Clin Psychiatry; 1979 Dec; 40(12):508-16. PubMed ID: 40964
[TBL] [Abstract][Full Text] [Related]
31. Neuroleptic-associated tardive syndromes.
Jeste DV; Wisniewski AA; Wyatt RJ
Psychiatr Clin North Am; 1986 Mar; 9(1):183-92. PubMed ID: 2870479
[TBL] [Abstract][Full Text] [Related]
32. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
Bai YM; Yu SC; Lin CC
J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
[TBL] [Abstract][Full Text] [Related]
33. [Tardive dyskinesia. A possible complication of chronic treatment with neuroleptics].
D'Aquila F; Rampello L
Riv Neurol; 1990; 60(4):140-5. PubMed ID: 1982720
[TBL] [Abstract][Full Text] [Related]
34. Tardive dyskinesia.
Goetz CG; Klawans HL
Neurol Clin; 1984 Aug; 2(3):605-14. PubMed ID: 6152483
[TBL] [Abstract][Full Text] [Related]
35. Neuroleptic-induced tardive dyskinesia.
Jenner P; Marsden CD
Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
[TBL] [Abstract][Full Text] [Related]
36. The differential diagnosis of tardive dyskinesia.
Casey DE
Acta Psychiatr Scand Suppl; 1981; 291():71-87. PubMed ID: 6941630
[TBL] [Abstract][Full Text] [Related]
37. Differential diagnosis of tardive dyskinesia: an overview.
Granacher RP
Am J Psychiatry; 1981 Oct; 138(10):1288-97. PubMed ID: 6457534
[TBL] [Abstract][Full Text] [Related]
38. [Tardive dyskinesia. Synthetic-critical review and case contribution].
Campanini T; Catalano A; De Risio C; Forino V
Ateneo Parmense Acta Biomed; 1977; 48(1):41-60. PubMed ID: 324489
[TBL] [Abstract][Full Text] [Related]
39. Modular algorithm for tardive dyskinesia diagnosis (MALTD): a demonstration of a methodological concept for diagnostic decision making.
Severe JB; Creecy RH
J Psychiatr Res; 1984; 18(3):245-53. PubMed ID: 6149318
[TBL] [Abstract][Full Text] [Related]
40. Drug-induced and other orofacial-cervical dyskinesias.
Jankovic J
Ann Intern Med; 1981 Jun; 94(6):788-93. PubMed ID: 7015951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
